View All Documents & Correspondence
A Composition For Inhibition Of Infrared Induced Aging And Uses Thereof
Abstract: The present disclosure relates to a composition comprising Moringa oliefera plant extract, and a tetra-peptide that inhibits infrared induced loss of collagen. The disclosure further provides formulations for topical application comprising said composition to ameliorate effects of photoaging.
Notices, Deadlines & Correspondence
Patent Information
Applicants
ITC LIMITED
Inventors
1. H, Ramya
2. JOIS, Prashanth
3. KUMARI, Deva
4. DIXIT, Ajay Kumar
5. CHANDRASEKHARAN, Lakshmanan Chittur
6. BANDYOPADHYAY, Balaji
Specification
CLIAMS:1. A composition for inhibition of infrared induced skin damage, said composition comprising:
a. Moringa oleifera extract; and
b. Tetra-peptide
2. The composition as claimed in claim 1, wherein the Moringa oleifera extract is obtained from plant parts consisting of leaf, root, stem, seeds, flower, fruit, drumstick and combinations thereof.
3. The composition as claimed in claim 2, wherein the Moringa oleifera extract is obtained from leaves.
4. The composition as claimed in claim 1, wherein the tetra-peptide is palmitoylated.
5. The composition as claimed in claim 1, wherein the tetra-peptide is Isoleucine-Glutamic acid-Proline-Aspartic acid (IEPD).
6. The composition as claimed in claim 1, wherein the concentration of Moringa oleifera extract is in the range of 1-15ppm, preferably 5ppm.
7. The composition as claimed in claim 1, wherein the concentration of tetra-peptide is in the range of 0.3-3ppm, preferably 1ppm.
8. A formulation for topical application comprising the composition as claimed in claim 1, further comprising suitable carriers, diluents, or excipients.
,TagSPECI:As Attached
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | IDF8 COMPLETE SPECIFICATION AS FILED.pdf | 2014-02-21 |
| 2 | FORM 5.pdf | 2014-02-21 |
| 3 | FORM 3.pdf | 2014-02-21 |
| 4 | FIGURES-IDF-8.pdf | 2014-02-21 |
| 5 | 798-CHE-2014 CORRESPONDENCE OTHERS 07-05-2014.pdf | 2014-05-07 |
| 6 | 798-CHE-2014 POWER OF ATTORNEY 07-05-2014.pdf | 2014-05-07 |
| 7 | 798-CHE-2014 FORM-1 07-05-2014.pdf | 2014-05-07 |
| 8 | 798-CHE-2014-FORM 18 [10-01-2018(online)].pdf | 2018-01-10 |
| 9 | 798-CHE-2014-FER.pdf | 2019-08-28 |
| 10 | 798-CHE-2014-OTHERS [21-02-2020(online)].pdf | 2020-02-21 |
| 11 | 798-CHE-2014-FER_SER_REPLY [21-02-2020(online)].pdf | 2020-02-21 |
| 12 | 798-CHE-2014-DRAWING [21-02-2020(online)].pdf | 2020-02-21 |
| 13 | 798-CHE-2014-CLAIMS [21-02-2020(online)].pdf | 2020-02-21 |
| 14 | 798-CHE-2014-Correspondence to notify the Controller [30-04-2021(online)].pdf | 2021-04-30 |
| 15 | 798-CHE-2014-Written submissions and relevant documents [19-05-2021(online)].pdf | 2021-05-19 |
| 16 | 798-CHE-2014-US(14)-HearingNotice-(HearingDate-06-05-2021).pdf | 2021-10-17 |
| 17 | 798-CHE-2014-PatentCertificate23-12-2023.pdf | 2023-12-23 |
| 18 | 798-CHE-2014-IntimationOfGrant23-12-2023.pdf | 2023-12-23 |
Search Strategy
| 1 | SS798CHE2014_09-08-2019.pdf |